publication | Pharmaceutical Compliance Monitor
Regulatory and Compliance Implications of Orphan Drugs
November 24, 2014
Intelligence That Works
BRG is home to renowned thought leaders and experts considered authorities in their fields of work. Our timely research and perspectives provide analysis and insights on the most important issues facing the industries and organizations we serve.
Edward Buthusiem and Gary Miller write about drug development and compliance, the Orphan Drug Act, and potential program incentives.
Related Professionals
Prepare for what's next.
ThinkSet magazine, a BRG publication, provides nuanced, multifaceted thinking and expert guidance that help today’s business leaders adopt a more strategic, long-term mindset to prepare for what’s next.